Fujimoto, D., Ueda, Y., Hirono, Y., Goi, T., & Yamaguchi, A. (2015). PAR1 participates in the ability of multidrug resistance and tumorigenesis by controlling Hippo-YAP pathway. Oncotarget.
استشهاد بنمط شيكاغوFujimoto, Daisuke, Yuki Ueda, Yasuo Hirono, Takanori Goi, و Akio Yamaguchi. "PAR1 Participates in the Ability of Multidrug Resistance and Tumorigenesis By Controlling Hippo-YAP Pathway." Oncotarget 2015.
MLA استشهادFujimoto, Daisuke, et al. "PAR1 Participates in the Ability of Multidrug Resistance and Tumorigenesis By Controlling Hippo-YAP Pathway." Oncotarget 2015.
تحذير: قد لا تكون هذه الاستشهادات دائما دقيقة بنسبة 100%.